Biomarkers of exposure: Hemoglobin adducts

Issues in Toxicology

Volumn 2, Issue , 2012, Pages 1-22

  Von Stedingk, H ^a   Osterman Golkar, S ^a   Tornqvist M ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898769106     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: None     Document Type: Article

References (73)

1. H. Jackson and R. Thompson, The reactions of some haemoglobin derivatives with 131I-labelled p-iodophenylhydroxylamine and piodonitrosobenzene, Biochem. J., 1953, 55, 36-37.
2. J. Lewalter and U. Korallus, Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring, Int. Arch. Occup. Environ. Health, 1985, 56, 179-196.
3. H. G. Neumann, Analysis of hemoglobin as a dose monitor for alkylating and arylating agents, Arch. Toxicol., 1984, 56, 1-6.
4. L. Ehrenberg, Genetic toxicity of environmental chemicals, Acta Biol. Yugosl. Ser. F: Genetika, 1974, 6, 367-398.
5. S. Osterman-Golkar, L. Ehrenberg, D. Segerbäck and I. Hällstrom, Evaluation of genetic risk of alkylating agents. II. Haemoglobin as dose monitor, Mutat. Res., 1976, 34, 1-10.
6. C. J. Calleman, L. Ehrenberg, B. Jansson, S. Osterman-Golkar, D. Segerback, K. Svensson and C. A. Wachtmeister, Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide, J. Environ. Pathol. Toxicol., 1978, 2, 427-442.
7. C. G. Swain and C. B. Scott, Quantitative correlation of relative rates. Comparison of hydroxide ion with other nucleophilic reagents towards alkyl halides, esters, epoxides and acyl halides, J. Am. Chem. Soc., 1953, 75, 141-147.
8. M. Törnqvist, C. Fred, J. Haglund, H. Helleberg, B. Paulsson and P. Rydberg, Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications, J. Chromatogr. B, 2002, 778, 279-308.
9. P. L. Skipper and S. R. Tannenbaum, Protein adducts in the molecular dosimetry of chemical carcinogens, Carcinogenesis, 1990, 11, 507-518.
10. F. N. Granath, C. E. Vaca, L. G. Ehrenberg and M. A. Törnqvist, Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model, Risk Anal., 1999, 19, 309-320.
11. D. Segerbäck, Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea, Carcinogenesis, 1990, 11, 307-312.
12. T. R. Fennell, J. P. MacNeela, M. J. Turner and A. Swenberg, Hemoglobin Adduct Formation by Acrylonitrile in Rats and Mice, Oxford University Press, 1991, pp. 241-246.
13. S. M. Osterman-Golkar and H. W. Vesper, Assessment of the relationship between glucose and A1c using kinetic modeling, J. Diabetes Complications, 2006, 20, 285-294.
14. J. K. Furne, J. R. Springfield, S. B. Ho and M. D. Levitt, Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival, J. Lab. Clin. Med., 2003, 142, 52-57.
15. R. A. Brace, C. Langendorfer, T. B. Song and D. M. Mock, Red blood cell life span in the ovine fetus, Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000, 279, R1196-R1204.
16. M. H. Dziegiel, O. Koldkjaer and A. Berkowicz, Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells, Transfusion, 2005, 45, 539-544.
17. T. R. Fennell, S. C. Sumner, R. W. Snyder, J. Burgess, R. Spicer, W. E. Bridson and M. A. Friedman, Metabolism and hemoglobin adduct formation of acrylamide in humans, Toxicol. Sci., 2005, 85, 447-459.
18. F. Granath, L. Ehrenberg and M. Tornqvist, Degree of alkylation of macromolecules in vivo from variable exposure, Mutat. Res., 1992, 284, 297-306.
19. T. R. Fennell, S. C. Sumner and V. E. Walker, A model for the formation and removal of hemoglobin adducts, Cancer Epidemiol. Biomarkers Prev., 1992, 1, 213-219.
20. G. Sabbioni and C. R. Jones, Biomonitoring of arylamines and nitroarenes, Biomarkers, 2002, 7, 347-421.
21. E. Richter and B. Branner, Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans, J. Chromatogr. B, 2002, 778, 49-62.
22. M. Tornqvist, J. Mowrer, S. Jensen and L. Ehrenberg, Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method, Anal. Biochem., 1986, 154, 255-266.
23. P. Rydberg, H. Von Stedingk, J. Magner and J. Bjorklund, LC/MS/MS analysis of N-terminal protein adducts with improved sensitivity: a comparison of selected Edman isothiocyanate reagents, Int. J. Anal. Chem., 2009, 2009, 153472.
24. 2 005101020, 63.
25. J. O. Jeppsson, U. Kobold, J. Barr, A. Finke, W. Hoelzel, T. Hoshino, K. Miedema, A. Mosca, P. Mauri, R. Paroni, L. Thienpont, M. Umemoto and C. Weykamp, Approved IFCC reference method for the measurement of HbA1c in human blood, Clin. Chem. Lab. Med., 2002, 40, 78-89.
26. G. Sabbioni, H. Wesp, J. Lewalter and R. Rumler, Determination of isocyanate biomarkers in construction site workers, Biomarkers, 2007, 12, 468-483.
27. P. B. Farmer, E. Bailey, S. M. Gorf, M. Tornqvist, S. Osterman-Golkar, A. Kautiainen and D. P. Lewis-Enright, Monitoring human exposure to ethylene oxide by the determination of haemoglobin adducts using gas chromatography-mass spectrometry, Carcinogenesis, 1986, 7, 637-640.
28. M. Ogawa, T. Oyama, T. Isse, T. Yamaguchi, T. Murakami, Y. Endo and T. Kawamoto, Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances, J. Occup. Health, 2006, 48, 314-328.
29. J. P. Teixeira, J. Gaspar, J. Roma-Torres, S. Silva, C. Costa, J. Roach, O. Mayan, J. Rueff and P. B. Farmer, Styrene-oxide N-terminal valine haemoglobin adducts in reinforced plasticworkers: possible influence of genetic polymorphism of drug-metabolising enzymes, Toxicology, 2007, 237, 58-64.
30. P. J. Boogaard, Use of haemoglobin adducts in exposure monitoring and risk assessment, J. Chromatogr. B, Anal. Technol. Biomed. Life Sci., 2002, 778, 309-322.
31. P. M. Vacek, R. J. Albertini, R. J. Sram, P. Upton and J. A. Swenberg, Hemoglobin adducts in 1, 3-butadiene exposed Czech workers: female-male comparisons, Chem. Biol. Interact., 2010, 188, 668-676.
32. E. Bergmark, C. J. Calleman, F. He and L. G. Costa, Determination of hemoglobin adducts in humans occupationally exposed to acrylamide, Toxicol. Appl. Pharmacol., 1993, 120, 45-54.
33. S. Sriramachari, G. J. Rao, V. K. Sharma, R. K. Jadhav, A. K. Saraf and H. Chandra, GC-NPD and GC-MS analysis of preserved tissue of Bhopal gas disaster: evidence of methyl carbamylation in post-mortem blood, Med. Sci. Law, 1991, 31, 289-293.
34. H. U. Kafferlein and J. Angerer, N-methylcarbamoylated valine of hemoglobin in humans after exposure to N, N-dimethylformamide: evidence for the formation of methyl isocyanate?, Chem. Res. Toxicol., 2001, 14, 833-840.
35. S. Rosqvist, G. Johannesson, C. H. Lindh and B. A. Jonsson, Total plasma protein adducts of allergenic hexahydrophthalic and methylhexahydrophthalic anhydrides as biomarkers of long-term exposure, Scand. J. Work Environ. Health, 2001, 27, 133-139.
36. R. Thier, H. Balkenhol, J. Lewalter, S. Selinski, A. Dommermuth and H. M. Bolt, Influence of polymorphisms of the human glutathione transferases and cytochrome P450 2E1 enzyme on the metabolism and toxicity of ethylene oxide and acrylonitrile, Mutat. Res., 2001, 482, 41-46.
37. C. J. Calleman, Y. Wu, F. He, G. Tian, E. Bergmark, S. Zhang, H. Deng, Y. Wang, K. M. Crofton and T. Fennell, Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide, Toxicol. Appl. Pharmacol., 1994, 126, 361-371.
38. L. Hagmar, M. Törnqvist, C. Nordander, I. Rosén, M. Bruze, A. Kautiainen, A.-L. Magnusson, B. Malmberg, P. Aprea, F. Granath and A. Axmon, Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose, Scand. J. Work Environ. Health, 2001, 27, 219-226.
39. B. Paulsson, K.-O. Larsen and M. Törnqvist, Hemoglobin adducts in the assessment of potential occupational exposure to acrylamides - three case studies, Scand. J. Work Environ. Health, 2006, 32, 154-159.
40. A. Wynckel, C. Randoux, H. Millart, C. Desroches, P. Gillery, E. Canivet and J. Chanard, Kinetics of carbamylated haemoglobin in acute renal failure, Nephrol. Dial. Transplant, 2000, 15, 1183-1188.
41. M. S. Bryant, H. F. Simmons, R. E. Harrell and J. A. Hinson, 2, 6-Dimethylaniline-hemoglobin adducts from lidocaine in humans, Carcinogenesis, 1994, 15, 2287-2290.
42. E. Bailey, P. B. Farmer, Y. S. Tang, H. Vangikar, A. Gray, D. Slee, R. M. Ings, D. B. Campbell, J. G. McVie and R. Dubbelman, Hydroxyethylation of hemoglobin by 1-(2-chloroethyl)-1-nitrosoureas, Chem. Res. Toxicol., 1991, 4, 462-466.
43. H. P. Benschop, G. P. Van Der Schans, D. Noort, A. Fidder, R. H. Mars-Groenendijk and L. P. De Jong, Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict, J. Anal. Toxicol., 1997, 21, 249-251.
44. R. M. Black, R. J. Clarke, J. M. Harrison and R. W. Read, Biological fate of sulphurmustard: identification of valine and histidine adducts in haemoglobin from casualties of sulphurmustard poisoning, Xenobiotica, 1997, 27, 499-512.
45. M. Tornqvist and A. Kautiainen, Adducted proteins for identification of endogenous electrophiles, Environ. Health Perspect., 1993, 99, 39-44.
46. E. Bergmark, Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers, Chem. Res. Toxicol., 1997, 10, 78-84.
47. E. Tareke, P. Rydberg, P. Karlsson, S. Eriksson and M. Tornqvist, Acrylamide: a cooking carcinogen?, Chem. Res. Toxicol., 2000, 13, 517-522.
48. E. Tareke, P. Rydberg, P. Karlsson, S. Eriksson and M. Tornqvist, Analysis of acrylamide, a carcinogen formed in heated foodstuffs, J. Agric. Food Chem., 2002, 50, 4998-5006.
49. L. Hagmar, E. Wirfält, B. Paulsson and M. Törnqvist, Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender, Mutat. Res., 2005, 580, 157-165.
50. E. Wirfalt, B. Paulsson, M. Tornqvist, A. Axmon and L. Hagmar, Associations between estimated acrylamide intakes and hemoglobin AA adducts in a sample from the Malmo Diet and Cancer cohort, Eur. J. Clin. Nutr., 2008, 62, 314-323.
51. M. Urban, D. Kavvadias, K. Riedel, G. Scherer and A. R. Tricker, Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers, Inhal. Toxicol., 2006, 18, 831-839.
52. G. Scherer, J. Engl, M. Urban, G. Gilch, D. Janket and K. Riedel, Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany, Regul. Toxicol. Pharmacol., 2007, 47, 171-183.
53. S. Chevolleau, C. Jacques, C. Canlet, J. Tulliez and L. Debrauwer, Analysis of hemoglobin adducts of acrylamide and glycidamide by liquid chromatographyelectrospray ionization tandem mass spectrometry, as exposure biomarkers in French population, J. Chromatogr. A, 2007, 1167, 125-134.
54. T. Bjellaas, P. T. Olesen, H. Frandsen, M. Haugen, L. H. Stoelen, J. E. Paulsen, J. Alexander, E. Lundanes and G. Becher, Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide, Toxicol. Sci., 2007, 98, 110-117.
55. H. W. Vesper, J. T. Bernert, M. Ospina, T. Meyers, L. Ingham, A. Smith and G. L. Myers, Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans, Cancer Epidemiol. Biomarkers Prev., 2007, 16, 2471-2478.
56. B. Kutting, W. Uter and H. Drexler, The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure, Cancer Causes Control, 2008, 19, 273-281.
57. B. Kutting, T. Schettgen, U. Schwegler, H. Fromme, W. Uter, J. Angerer and H. Drexler, Acrylamide as environmental noxious agent: a health risk assessment for the general population based on the internal acrylamide burden, J. Hyg. Environ. Health, 2009, 212, 470-480.
58. P. T. Olesen, A. Olsen, H. Frandsen, K. Frederiksen, K. Overvad and A. Tjoenneland, Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health study, Int. J. Cancer, 2008, 122, 2094-2100.
59. H. W. Vesper, N. Slimani, G. Hallmans, A. Tjonneland, A. Agudo, V. Benetou, S. Bingham, H. Boeing, M. C. Boutron-Ruault, H. B. Bueno-de-Mesquita, D. Chirlaque, F. Clavel-Chapelon, F. Crowe, D. Drogan, P. Ferrari, I. Johansson, R. Kaaks, J. Linseisen, E. Lund, J. Manjer, A. Mattiello, D. Palli, P. H. Peeters, S. Rinaldi, G. Skeie, A. Trichopoulou, P. Vineis, E. Wirfalt, K. Overvad and U. Stromberg, Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study, J. Agric. Food Chem., 2008, 56, 6046-6053.
60. K. M. Wilson, K. Balter, H. O. Adami, H. Gronberg, A. C. Vikstrom, B. Paulsson, M. Tornqvist and L. A. Mucci, Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study, Int. J. Cancer, 2009, 124, 2384-2390.
61. A. C. Vikstrom, K. M. Wilson, B. Paulsson, I. Athanassiadis, H. Gronberg, H. O. Adami, J. Adolfsson, L. A. Mucci, K. Balter and M. Tornqvist, Alcohol nfluence on acrylamide to glycidamide metabolismassessedwith hemoglobinadducts and questionnaire data, Food Chem. Toxicol., 2010, 48, 820-824.
62. K. M. Wilson, H. W. Vesper, P. Tocco, L. Sampson, J. Rosen, K. E. Hellenas, M. Tornqvist and W. C. Willett, Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide, Cancer Causes Control, 2009, 20, 269-278.
63. H. W. Vesper, S. P. Caudill, J. D. Osterloh, T. Meyers, D. Scott and G. L. Myers, Exposure of the U. S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004, Environ. Health Perspect., 2010, 118, 278-283.
64. A. C. Vikstrom, L. Abramsson-Zetterberg, M. Naruszewicz, I. Athanassiadis, F. N. Granath and M. A. Tornqvist, In vivo doses of acrylamide and glycidamide in humans after intake of acrylamide-rich food, Toxicol. Sci., 2011, 119, 41-49.
65. T. R. Fennell, J. P. MacNeela, R. W. Morris, M. Watson, C. L. Thompson and D. A. Bell, Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes, Cancer Epidemiol. Biomarkers Prev., 2000, 9, 705-712.
66. H. U. Kafferlein, B. Marczynski, T. Mensing and T. Bruning, Albumin and hemoglobin adducts of benzo[a]pyrene in humans - analytical methods, exposure assessment, and recommendations for future directions, Crit. Rev. Toxicol., 2010, 40, 126-150.
67. Y. S. Lin, P. P. Egeghy and S. M. Rappaport, Relationships between levels of volatile organic compounds in air and blood from the general population, J. Expo. Sci. Environ. Epidemiol, 2008, 18, 421-429.
68. L. F. McCoy, P. F. Scholl, A. E. Sutcliffe, S. M. Kieszak, C. D. Powers, H. S. Rogers, Y. Y. Gong, J. D. Groopman, C. P. Wild and R. L. Schleicher, Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry, Cancer Epidemiol. Biomarkers Prev., 2008, 17, 1653-1657.
69. A. Kumar, P. Vineis, C. Sacerdote, L. Fiorini and G. Sabbioni, Determination of new biomarkers to monitor the dietary consumption of isothiocyanates, Biomarkers, 2010, 15, 739-745.
70. J. C. Kang-Sickel, V. P. Stober, J. E. French and L. A. Nylander-French, Exposure to naphthalene induces naphthyl-keratin adducts in human epidermis in vitro and in vivo, Biomarkers, 2010, 15, 488-497.
71. H. Von Stedingk, P. Rydberg and M. Tornqvist, A new modified Edman procedure for analysis of N-terminal valine adducts in hemoglobin by LC-MS/MS, J. Chromatogr. B, 2010, 878, 2483-2490.
72. H. W. Vesper, M. Ospina, T. Meyers, L. Ingham, A. Smith, J. G. Gray and G. L. Myers, Automated method for measuring globin adducts of acrylamide and glycidamide at optimized Edman reaction conditions, Rapid Commun. Mass Spectrom., 2006, 20, 959-964.
73. W. E. Funk, S. Waidyanatha, S. H. Chaing and S. M. Rappaport, Hemoglobin adducts of benzene oxide in neonatal and adult dried blood spots, Cancer Epidemiol. Biomarkers Prev., 2008, 17, 1896-1901.